Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Incyte Corp - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
INCY
Nasdaq
2834
https://www.incyte.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Incyte Corp
Mesoblast (MESO) to File Pediatric GVHD Drug BLA, Stock Up
- Mar 27th, 2024 3:00 pm
SEC Tests Insider-Trading Theory at Trial of Ex-Biotech Executive
- Mar 26th, 2024 6:47 pm
30 Biggest Biotechnology Companies in the World
- Mar 17th, 2024 12:50 pm
Why Is Incyte (INCY) Up 1.8% Since Last Earnings Report?
- Mar 14th, 2024 3:30 pm
Incyte (INCY) Posts Positive Results on Opzelura From HS Study
- Mar 12th, 2024 5:52 pm
Penny Stock Detox: 3 Stocks to Buy for Multibagger Returns Instead
- Mar 11th, 2024 5:02 pm
Incyte Announces New Data from Phase 2 Study Evaluating Ruxolitinib Cream (Opzelura®) in Patients with Mild-to-Moderate Hidradenitis Suppurativa
- Mar 10th, 2024 8:05 pm
Incyte Presents New Late-Breaking Data from Phase 2 Study Evaluating Povorcitinib in Patients with Prurigo Nodularis
- Mar 10th, 2024 8:05 pm
3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise
- Mar 7th, 2024 8:00 pm
New Data from Incyte’s Growing Dermatology Portfolio to be Presented at the 2024 American Academy of Dermatology (AAD) Annual Meeting
- Mar 4th, 2024 1:00 pm
Incyte Launches The Unseen Journey to Elevate the Hidden Impact of Myeloproliferative Neoplasms (MPNs) on Patients’ Lives through Generative AI
- Feb 29th, 2024 3:19 pm
Knight Therapeutics Announces Launch of Minjuvi® in Brazil
- Feb 29th, 2024 12:30 pm
Q4 2023 Syndax Pharmaceuticals Inc Earnings Call
- Feb 28th, 2024 6:10 pm
Incyte Announces U.S. Food and Drug Administration Grants Priority Review for Axatilimab for the Treatment of Chronic Graft-Versus-Host Disease
- Feb 27th, 2024 9:08 pm
7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
- Feb 26th, 2024 8:20 pm
Exit Now! 3 Biotech Stocks to Sell in February 2024
- Feb 21st, 2024 9:50 pm
Incyte to Present at Upcoming Investor Conference
- Feb 15th, 2024 1:00 pm
Incyte Corporation (NASDAQ:INCY) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year
- Feb 15th, 2024 11:03 am
Incyte Corporation (NASDAQ:INCY) Q4 2023 Earnings Call Transcript
- Feb 14th, 2024 2:32 pm
Q4 2023 Incyte Corp Earnings Call
- Feb 14th, 2024 6:15 am
Scroll